Unique human immune signature of Ebola virus disease in Guinea. - Wikidata - wikimedia - TriplyDB

Unique human immune signature of Ebola virus disease in Guinea.

Unique human immune signature of Ebola virus disease in Guinea.

http://www.wikidata.org/entity/Q34525050

about

Acute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor Function Enabling Rapid Response to the 2014-2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani.Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization.Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections.Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies.The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus.Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination.Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut.Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants.Ebola Virus Disease in Humans: Pathophysiology and Immunity.Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses.Considerations for use of Ebola vaccine during an emergency response.Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.Filovirus Strategies to Escape Antiviral Responses.Humanized Mice Reproduce Acute and Persistent Human Adenovirus Infection.Sepsis in PD-1 light.Host Transcriptional Response to Ebola Virus Infection.Exploring the Immunopathogenesis of Viral Hemorrhagic Fever in Mice with a Humanized Immune System.Comparison of Transcriptomic Platforms for Analysis of Whole Blood from Ebola-Infected Cynomolgus Macaques.Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis.Immune barriers of Ebola virus infection.Differential expression pattern of co-inhibitory molecules on CD4+ T cells in uncomplicated versus complicated malaria.Disabling of lymphocyte immune response by Ebola virus.A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals.Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection

P2860

Q28109688-F192A756-B2DC-4710-A9AB-345418705827 Q30151599-3DFAE77C-9836-4071-9777-EC3722BAD0BD Q33715773-082D47FC-5357-41A1-BDA0-06F8D71DFFFE Q33803364-D1DC5BFA-5D31-4548-A5FA-A0798C3A817D Q36178499-7EA5012F-1100-49BF-A3C5-E1DEEC33EDB9 Q36216308-4FF713DD-A3F2-4FBD-967F-A23FCC919B80 Q37593571-9ED8C206-CF14-4D21-8551-15B718071AF1 Q37678872-6C318B58-6E7F-4FFA-B9EA-3B2C60C59A0C Q38598481-AFADCAB1-73B2-4370-98F5-6C2C1E4B035A Q38603013-C7892077-3374-413E-8DF5-D0E027987230 Q38707770-C64B363A-4E9A-4C58-8619-C42332697CE0 Q38711125-6A51011F-2602-4B00-A21A-966F07406FE0 Q38848150-B9F9E6D1-DB54-4FDD-A0EE-DE77102F0D19 Q40039769-95226014-1C24-4BD9-B10E-C5B9F02DBF3A Q40061262-4C49D13C-5BDB-4C6C-997A-2ED9FD6E9B95 Q40132236-8E2EF0D7-ABFD-4576-9240-95DCC3ABAB7D Q40375992-DD7D3CE1-C79C-4319-ADC0-F39B6F6E6D91 Q40625575-FD36A40C-315F-4DFE-9FD5-EBA8578D8959 Q41905593-3DE3F35A-3105-475F-9814-B275EC61AF60 Q41919588-F2A13257-DC15-4D91-A074-759453FF0652 Q44106105-5BFA6D03-4BEB-4CAE-8475-057E00FCF2C1 Q44106136-2C813F03-3C8C-4554-B5B5-09DC371BAF53 Q49917351-3436B0C3-2697-48DC-902E-BB1FF02995A8 Q52647950-BDCEDB1F-EACD-48A2-B90E-E7EC3C51D782 Q54107921-3C895ED9-5345-44F1-BA36-004952F3F46A Q55286894-BB7A2C35-0F89-406C-AAEF-CB417F4861AC Q57059911-350545C9-F254-40D1-A9D5-31C35964ABDE Q58765534-6E130659-22E8-4DB1-84F7-A681A3E47AE0

P2860

Unique human immune signature of Ebola virus disease in Guinea.

http://www.wikidata.org/entity/Q34525050

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Unique human immune signature of Ebola virus disease in Guinea.

@ast

Unique human immune signature of Ebola virus disease in Guinea.

@en

Unique human immune signature of Ebola virus disease in Guinea.

@nl

type

label

Unique human immune signature of Ebola virus disease in Guinea.

@ast

Unique human immune signature of Ebola virus disease in Guinea.

@en

Unique human immune signature of Ebola virus disease in Guinea.

@nl

prefLabel

Unique human immune signature of Ebola virus disease in Guinea.

@ast

Unique human immune signature of Ebola virus disease in Guinea.

@en

Unique human immune signature of Ebola virus disease in Guinea.

@nl

P1433

Q34525050-988B36B0-C0AD-4966-8A98-5BF0C8C602CD

P1476

Q34525050-8ABB2636-0E4C-48BE-86AB-27DC2218E1FC

P2093

Q34525050-02DDEB0D-770D-4689-A188-DCC58565628A

Q34525050-0D5775FC-2C64-4AFF-BBAF-ABB8E88C008D

Q34525050-14423313-56FF-42DF-A833-81B2CAD95E6C

Q34525050-15AE642A-B26B-48E6-ABEB-7E492B235C82

Q34525050-275F58F6-EE66-4DF3-A610-4BE1E65D41E1

Q34525050-2EC41905-8BA7-483B-9442-9A56CB46FD88

Q34525050-2EFFC8F9-6FE2-479D-96F0-9A43E14ED017

Q34525050-2FE9AAB5-3618-4DA9-A66D-69E0361B18C4

Q34525050-301DBCE7-D61F-458D-9F41-D29F5C5DAB97

Q34525050-3336C730-1018-4A01-9AB9-E3D88BDE69F4

P2860

Q34525050-1BC6C3B7-EFC5-4F44-AC66-F1AA0B3CCC4F

Q34525050-24CC7F65-DF5B-457F-9ED0-DAB8B10AB885

Q34525050-27100710-A2F1-45B0-B256-4C5BEF4152A7

Q34525050-4051014A-14AF-49F0-B727-7BB11136FAA9

Q34525050-4AC67736-C2E0-4CEF-B074-AB8BCAC5444C

Q34525050-4B90F736-4EAA-4C47-89F0-C3AE5EBE506D

Q34525050-5839A338-30B5-45A7-B9BE-E93836BE41EE

Q34525050-5B6F1499-5C1C-4C3F-BCE4-37D452B76C9F

Q34525050-5F54FB61-D3C6-42F7-A019-5E397B89216E

Q34525050-60CE7A45-0B08-45CF-9AB9-3D181B144854

P2888

Q34525050-6A1D580F-05C3-4308-9201-9FB83333C642

P304

Q34525050-94582B9F-E222-47D3-A3FA-66883F1AC316

P31

Q34525050-BAE23938-53C7-4FD0-BD70-628B0EB5BA6E

P356

Q34525050-D469F0CB-CE6B-4CDE-872F-F517A5FA2500

P407

Q34525050-343AFE8D-087A-46DE-8057-90F63515ACE1

P433

Q34525050-1ED19DB9-20FD-43FA-927C-6699F6585AA6

P478

Q34525050-EC88EAD8-E3B7-4590-95BF-CA976A728BA3

P50

Q34525050-016D2F0D-71E1-486D-A688-F280092F709F

Q34525050-1650B69A-59A6-4EF6-962C-E9031746D741

Q34525050-22E2F41E-488E-403D-B119-5A034D67CDD4

Q34525050-2E959C62-8050-42A5-BBAB-1F7DDB62B159

Q34525050-36B2813E-2A80-4906-A9BA-16B5D92B6C96

Q34525050-39EB06EA-8BA8-4512-B8C1-69D3D1226497

Q34525050-4B93BD37-BC5F-4247-ACA6-B6EBABE4DEA3

Q34525050-58E2345D-B8C3-4B0D-88BC-CD2E93DDAC98

Q34525050-61ACF21B-9B33-4F7F-AF1E-F89B759D85DD

Q34525050-64EF9BD4-C092-4E5E-8F4C-72E264AE70F1

P577

Q34525050-AABAED31-581C-47DB-B426-AC287E304FCF

P698

Q34525050-F597C087-7933-4655-BCDD-2D492F746831

P921

Q34525050-5D200495-DB9D-40E1-B45E-942F3ED495A9

Q34525050-87C18587-BB11-42EB-AA86-A8CBC332987E

Q34525050-C19BE930-D18B-4187-936E-B9406946FDD3

P932

Q34525050-67D3BC04-29B9-4AA1-9AEB-9EC72A57279B

P356

P1433

P1476

Unique human immune signature of Ebola virus disease in Guinea.

@en

P2093

Alexandra Fizet

http://www.w3.org/2001/XMLSchema#string

Amadou Bah

http://www.w3.org/2001/XMLSchema#string

Anabel Negredo

http://www.w3.org/2001/XMLSchema#string

Andreas Kurth

http://www.w3.org/2001/XMLSchema#string

Andreas Sachse

http://www.w3.org/2001/XMLSchema#string

Anja Lüdtke

http://www.w3.org/2001/XMLSchema#string

Anja Thorenz

http://www.w3.org/2001/XMLSchema#string

Anne Bocquin

http://www.w3.org/2001/XMLSchema#string

Anne Kelterbaum

http://www.w3.org/2001/XMLSchema#string

Ansgar W Lohse

http://www.w3.org/2001/XMLSchema#string

P2860

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

Immunoregulatory molecules are master regulators of inflammation during the immune response

HLA class I in three West African ethnic groups: genetic distances from sub-Saharan and Caucasoid populations

T cell exhaustion

Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.

Clinical illness and outcomes in patients with Ebola in Sierra Leone.

Human Ebola virus infection results in substantial immune activation.

The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology.

Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.

P2888

P304

100-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE17949

http://www.w3.org/2001/XMLSchema#string

P407

P433

7601

http://www.w3.org/2001/XMLSchema#string

P478

533

http://www.w3.org/2001/XMLSchema#string

P50

Tatjana Avšič Županc

Stephan Günther

Antonino Di Caro

Sophie Duraffour

Pierre Formenty

Lamine Koivogui

Kilian Stoecker

Mary Carrington

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27147028

http://www.w3.org/2001/XMLSchema#string

P921

2014 Ebola virus epidemic in Guinea

Ebola virus disease

P932

4876960

http://www.w3.org/2001/XMLSchema#string